Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Applied Molecular Transport Inc.

Applied Molecular Transport Reports Third Quarter 2023 Financial Results
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Reports First Quarter 2023 Financial Results
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 Congress
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of Pouchitis
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport to Present at Upcoming November Investor Conferences
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Applied Molecular Transport Inc.
Via GlobeNewswire
Tickers AMTI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.